secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001104659-23-040192
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris raises $27.5M via sale of 3.4M shares to Bain Capital affiliates
------------------------------------------------------------------------

- Sold 3.4M shares of common stock for aggregate gross proceeds of $27.5M.
- Shares purchased by entities affiliated with Bain Capital Life Sciences.
- Sale executed under existing ATM agreement with SVB Securities and Cantor Fitzgerald.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000110465923040192/0001104659-23-040192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000110465923040192/tm2311197d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-040192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer